in-20260225-IR-405260059ONA: OFFICE OF THE SECRETARY OF FAMILY AND SOCIAL SERVICES

OFFICE OF THE SECRETARY OF FAMILY AND SOCIAL SERVICES Notice of Update to the 340B Drug Program In accordance with public notice requirements established at 42 CFR 447.204 and 42 CFR 447.205, the Indiana Family and Social Services Administration (FSSA), Office of Medicaid Policy and Planning (OMPP) publishes this notice of proposed changes to methods and standards governing the 340B Drug Program. The public notice period is from February 25, 2026, to March 27, 2026. FSSA – OMPP intends to amend the Medicaid State Plan to fully discontinue Medicaid reimbursement for drugs purchased under the federal 340B Drug Pricing Program. Under this amendment, OMPP will instead seek manufacturer rebates through the Medicaid Drug Rebate Program for all covered outpatient drugs, ensuring alignment with federal requirements and supporting consistent, transparent reimbursement across the pharmacy benefit. The proposed change is estimated to be a cost savings in annual aggregate expenditures. These changes are effective July 1, 2026. A copy of this notice is now on file at the Indiana Government Center South, 402 West Washington Street, Room W451, Indianapolis, Indiana and is open for public inspection. Also, a copy of this notice is now available and may be inspected by contacting the local county Division of Family Resources office, except in Marion County, where public inspection may be made at 402 West Washington Street, Room W374, Indianapolis, Indiana. There will be no public hearing. Written comments will be accepted until 5 p.m. on March 27, 2026, and may be directed to FSSA, Office of Medicaid Policy and Planning, Attention: Conner Ortman, 402 West Washington Street, Room W374, Indianapolis, IN 46204 or by email to spacomment@fssa.in.gov. Correspondence should be identified in the following manner: COMMENT RE: 340B DRUG PROGRAM. Written comments will be made available for public inspection at the address herein of OMPP.